Cephalexin USP is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Jazeera Pharmaceutical. The primary component is Cephalexin Anhydrous.
| Product ID | 68289-008_24fc53ef-d9ef-401a-8bbe-3fc0d76a6cf8 |
| NDC | 68289-008 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Cephalexin USP |
| Generic Name | Cephalexin |
| Dosage Form | Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2009-09-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA065444 |
| Labeler Name | Jazeera Pharmaceutical |
| Substance Name | CEPHALEXIN ANHYDROUS |
| Active Ingredient Strength | 125 mg/5mL |
| Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 2009-09-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA065444 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-09-01 |
| Inactivation Date | 2019-10-21 |
| Marketing Category | ANDA |
| Application Number | ANDA065444 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-09-01 |
| Inactivation Date | 2019-10-21 |
| Ingredient | Strength |
|---|---|
| CEPHALEXIN ANHYDROUS | 125 mg/5mL |
| SPL SET ID: | 2b388b1e-cd59-42de-ba72-858485b070b7 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 68289-008 | Cephalexin USP | Cephalexin USP |
| 68289-009 | Cephalexin USP | Cephalexin USP |
| 0093-2238 | Cephalexin | Cephalexin |
| 0093-2240 | Cephalexin | Cephalexin |
| 0093-3145 | Cephalexin | Cephalexin |
| 0093-3147 | Cephalexin | Cephalexin |
| 0093-4175 | Cephalexin | Cephalexin |
| 0093-4177 | Cephalexin | Cephalexin |
| 0143-9769 | Cephalexin | Cephalexin |
| 0143-9770 | Cephalexin | Cephalexin |
| 0143-9897 | Cephalexin | Cephalexin |
| 0143-9898 | Cephalexin | Cephalexin |